(PDF) A Clinical Study on Adverse Drug Reactions of

A Clinical Study on Adverse Drug Reactions of Combination Therapy of Dapagliflozin and Metformin in the Treatment of Type 2 Diabetes Mellitus

Asian Journal of Pharmaceutical and Clinical Research - India

doi 10.22159/ajpcr.2017.v10i3.16380

Full Text

Abstract

Available in full text

Categories

Pharmaceutical Science

Date

March 1, 2017

Authors

Syed Safiullah Ghori

Publisher

Innovare Academic Sciences Pvt Ltd

Related search

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology

English

Dapagliflozin: A New Adjunct in the Treatment of Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology

English

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

JAMA - Journal of the American Medical Association

English

Comparison of Antioxidative Effect of Metformin and Combination of Metformin-Sulfonylurea in Type 2 Diabetes Mellitus Patients

Journal of Young Pharmacists

English

Dapagliflozin: Cost-Effectiveness as an Add-On Therapy to Metformin in the Treatment of Type 2 Diabetes (T2DM) in Argentina and Chile

Value in Health

Occupational Health

English

Combination of Empagliflozin and Metformin Therapy: A Consideration of Its Place in Type 2 Diabetes Therapy

Clinical Medicine Insights: Endocrinology and Diabetes

Internal Medicine

English

Pharmacoeconomic Analysis of the Use of a Fixed Dose Combination of Metformin and Glibenclamide in the Therapy of Diabetes Mellitus Type 2

Pharmacoeconomics: theory and practice

English

Cost Effectiveness Evaluation of Canagliflozin in Combination With Metformin in the Treatment of Type 2 Diabetes Mellitus in Poland

Value in Health

Occupational Health

English

Cost-Effectiveness of First-Line Versus Delayed Use of Combination Dapagliflozin and Metformin in Patients With Type 2 Diabetes

Scientific Reports

Multidisciplinary

English